Atomoxetine vs Amphetamine/Dextroamphetamine

For ADHD symptom control, stimulants including Adderall are generally considered more effective than non-stimulants for the majority of patients ^[3][4].

Adderall produces noticeable improvement in ADHD symptoms within 30-60 minutes of the first dose, with robust effect sizes (Cohen's d approximately 0.7-0.9) in clinical trials ^[2][4]. Response rates (meaningful improvement) are approximately 70-80% for stimulant medications as a class. Adderall improves attention, reduces impulsivity, and decreases hyperactivity reliably in most patients ^[2].

Atomoxetine has a slower onset, requiring 4-6 weeks of continuous daily dosing to reach full therapeutic effect ^[1]. Its effect sizes are more modest (Cohen's d approximately 0.4-0.7), and response rates are approximately 50-60% ^[3]. However, atomoxetine provides continuous 24-hour coverage without the wearing-off effect seen with stimulants, and its effects do not fluctuate throughout the day ^[1].

The NIMH MTA study and subsequent meta-analyses have consistently shown that stimulant medications produce greater ADHD symptom improvement than non-stimulants ^[4]. However, atomoxetine is a valuable option for patients who cannot tolerate stimulants, have comorbid anxiety (where it may be particularly effective), have substance abuse concerns, or prefer a non-controlled medication ^[1][3].

The side effect profiles reflect their different mechanisms ^[1][2].

Atomoxetine's most common side effects include decreased appetite (16%), nausea (26%), vomiting (11%), fatigue (10%), abdominal pain, and mood swings ^[1]. It carries an FDA boxed warning for increased risk of suicidal thinking in children and adolescents, similar to antidepressants ^[1]. Less common but notable effects include liver injury (rare but serious — discontinue if jaundice or dark urine occur), increased heart rate and blood pressure, urinary hesitancy, and sexual dysfunction (erectile dysfunction, decreased libido in adults) ^[1]. Atomoxetine does NOT cause insomnia, appetite suppression as severe as stimulants, or tics, and has NO abuse potential.

Adderall's most common side effects include decreased appetite (22%), insomnia (17%), dry mouth, abdominal pain, weight loss, anxiety, and irritability ^[2]. Cardiovascular effects include increased heart rate and blood pressure. Serious risks include potential for psychological dependence and abuse, exacerbation of psychotic symptoms, cardiovascular events (rare, primarily in patients with pre-existing conditions), growth suppression in children with long-term use, and peripheral vasculopathy (Raynaud's phenomenon) ^[2]. Adderall can worsen tics in some patients and can cause significant rebound irritability as doses wear off.

A key differentiator: Adderall's stimulant effects make it a target for diversion and misuse, particularly in college and young adult populations. Atomoxetine has no street value and minimal diversion risk ^[1][2].

Generic atomoxetine (10-100 mg capsules) costs approximately $15-$40 for a 30-day supply ^[5]. Generic mixed amphetamine salts (Adderall generic, immediate-release) cost $15-$30 for a 30-day supply. Generic Adderall XR is $20-$50/month ^[5].

Brand-name Strattera costs $350-$450/month. Brand-name Adderall XR costs $250-$350/month. Insurance coverage is generally good for both, though some plans require prior authorization or step therapy (trying a stimulant first before approving atomoxetine).

Atomoxetine is taken once or twice daily (total dose 40-100 mg/day) and provides continuous 24-hour ADHD coverage without wearing off ^[1]. It does not require dose timing around school or work activities. There is no "drug holiday" consideration since it must be taken daily to maintain effect.

Adderall immediate-release lasts 4-6 hours and may need twice-daily dosing ^[2]. Adderall XR lasts 10-12 hours with once-daily morning dosing. The wearing-off effect means afternoon/evening symptoms may not be covered, though this can also be viewed as allowing appetite recovery and easier sleep. As a Schedule II controlled substance, Adderall prescriptions cannot be called in to pharmacies in many states and may require monthly office visits for refills ^[2].

Adderall (or another stimulant) is generally the first-line choice for ADHD due to higher response rates and faster onset of action ^[2][4]. It is preferred when rapid symptom improvement is needed, when the patient has no contraindications to stimulants, and when diversion/abuse risk can be adequately managed.

Atomoxetine is preferred when stimulants are contraindicated or not tolerated, when there is a history of substance abuse or high diversion risk, when comorbid anxiety is prominent (atomoxetine treats both), when 24-hour coverage without wearing off is important, when insomnia from stimulants is unmanageable, or when patients/families prefer a non-controlled medication ^[1][3].

This information is for educational purposes only and does not constitute medical advice. ADHD treatment should be individualized by your healthcare provider based on symptom profile, comorbidities, and risk factors.